Cigna
About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
Employees: 73,500
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 10 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
12% more call options, than puts
Call options by funds: $1.06B | Put options by funds: $946M
0.65% more ownership
Funds ownership: 86.68% [Q3] → 87.33% (+0.65%) [Q4]
4% less funds holding
Funds holding: 1,672 [Q3] → 1,602 (-70) [Q4]
14% less first-time investments, than exits
New positions opened: 178 | Existing positions closed: 208
20% less capital invested
Capital invested by funds: $83.8B [Q3] → $67B (-$16.8B) [Q4]
20% less repeat investments, than reductions
Existing positions increased: 522 | Existing positions reduced: 653
35% less funds holding in top 10
Funds holding in top 10: 34 [Q3] → 22 (-12) [Q4]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$339
2%
upside
Avg. target
$365
10%
upside
High target
$390
18%
upside
10 analyst ratings
9 positive
90%
1 neutral
10%
0 negative
0%
Cantor Fitzgerald Sarah James 35% 1-year accuracy 39 / 113 met price target | 10%upside $365 | Overweight Maintained | 20 Mar 2025 |
Truist Securities David Macdonald 62% 1-year accuracy 58 / 93 met price target | 13%upside $375 | Buy Maintained | 4 Feb 2025 |
Wells Fargo Stephen Baxter 32% 1-year accuracy 12 / 37 met price target | 3%upside $341 | Equal-Weight Maintained | 4 Feb 2025 |
UBS Kevin Caliendo 50% 1-year accuracy 7 / 14 met price target | 18%upside $390 | Buy Maintained | 3 Feb 2025 |
Piper Sandler Jessica Tassan 38% 1-year accuracy 9 / 24 met price target | 5%upside $348 | Overweight Reiterated | 3 Feb 2025 |
Financial journalist opinion
Based on 7 articles about CI published over the past 30 days
Positive
Seeking Alpha
1 day ago
The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna achieved 8%-9% YoY EPS growth in 2023-2024, demonstrating strong cost discipline and effective management. The sale of Cigna's Medicare unit and focus on lower-cost biosimilars and streamlined care accessibility are key strategic moves for future growth.
Neutral
GlobeNewsWire
6 days ago
MissionSquare Retirement Earns 2024 Cigna Healthy Workforce Designation™ for the second year in a row
Washington, D.C., March 26, 2025 (GLOBE NEWSWIRE) -- Cigna Healthcare has selected MissionSquare, an organization that advocates for retirement security and financial well-being, as a recipient of their 2024 Gold Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program.
Negative
Zacks Investment Research
1 week ago
New Strong Sell Stocks for March 20th
AIN, EFX and CI have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2025.
Neutral
PRNewsWire
1 week ago
The Cigna Group Completes Sale of Medicare Businesses to HCSC
BLOOMFIELD, Conn. , March 19, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC).
Neutral
Reuters
2 weeks ago
Cigna shuffles executive roles, names Ann Dennison as CFO
Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's chief operating officer, and promoting his deputy Ann Dennison to the top finance role.
Neutral
PRNewsWire
2 weeks ago
The Cigna Group announces leadership changes to accelerate the company's growth strategy
Brian Evanko named President and Chief Operating Officer, The Cigna Group Ann Dennison named Executive Vice President and Chief Financial Officer, The Cigna Group Nicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise Marketing Eric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna Group Reaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn. , March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE: CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.
Neutral
Seeking Alpha
2 weeks ago
The Cigna Group (CI) Barclays 27th Annual Global Healthcare Conference (Transcript)
The Cigna Group (NYSE:CI ) Barclays 27th Annual Global Healthcare Conference Call March 12, 2025 2:00 PM ET Company Participants Brian Evanko - Chief Financial Officer of Cigna Group, President, Chief Executive Officer of Cigna Healthcare Conference Call Participants Andrew Mok - Barclays Andrew Mok Hi, good afternoon and welcome back to the Barclays Global Healthcare Conference. My name is Andrew Mok, I'm the facilities and managed care analyst here at Barclays.
Positive
Seeking Alpha
1 month ago
5 Relatively Secure And Cheap Dividend Stocks, Yields Upto 8% (March 2025)
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.63%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.
Positive
Seeking Alpha
1 month ago
31 Upcoming Dividend Increases, Including 3 Kings
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strategy prioritizes companies with consistently rising dividends and outperforming benchmarks, aiming for long-term wealth accumulation and portfolio prosperity. I use data from the "U.S. Dividend Champions" spreadsheet and NASDAQ to identify companies with at least five years of dividend growth.
Neutral
PRNewsWire
1 month ago
The Cigna Group Announces Appearance at Barclays 27th Annual Global Healthcare Conference
BLOOMFIELD, Conn. , Feb. 26, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, and President and CEO of Cigna Healthcare, will present at Barclays 27th Annual Global Healthcare Conference on March 12, 2025, through a virtual webcast.
Charts implemented using Lightweight Charts™